Caitlin Stashwick

Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells

János L. Tanyi, Caitlin Stashwick, Gabriela Plesa et al. · Journal of Immunotherapy · 2017 · 84 citations

T-regulatory Cell, Immune Regulation, Immunology +27

Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy

Jenessa B. Smith, Evripidis Lanitis, Denarda Dangaj Laniti et al. · Molecular Therapy · 2016 · 56 citations · Full text

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells

Katarzyna Urbańska, Rachel C. Lynn, Caitlin Stashwick et al. · Journal of Translational Medicine · 2014 · 49 citations · Full text

Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer

Katarzyna Urbańska, Caitlin Stashwick, Mathilde Poussin et al. · Cancer Immunology Research · 2015 · 46 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +19

Anti-mesothelin chimeric antigen receptor T cells in patients with epithelial ovarian cancer.

János L. Tanyi, Andrew R. Haas, Gregory L. Beatty et al. · Journal of Clinical Oncology · 2016 · 37 citations

Clinical Immunology, Epithelial Ovarian Cancer, Immunology +18